Opko Health OPK Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Segment Reporting Other Item Amount by Business | ||||||
| Diagnostics | -$18.07M— | —— | —— | -$101.58M+16.4% | $0— | |
| Pharmaceutical | $0— | —— | $0— | $0— | $0— | |
| Revenue by Product | ||||||
| Intellectual Property And Other | $46.1M+207% | $14M+13.8% | —— | $18.7M+41.7% | $15M+22.0% | |
| Rayaldee | $14.26M-1.8% | $12.81M-2.3% | $16.87M-15.0% | $14.88M-6.2% | $14.53M-21.1% | |
| Royalty | $6.4M+4.9% | —— | —— | —— | $6.1M— | |
| Transfer Of Intellectual Property And Other | $46.09M+208% | $13.97M+13.6% | $33.72M-21.8% | $18.75M+41.8% | $14.96M+21.6% | |
| Revenue by Geography | ||||||
| CL | $16.43M+2.7% | $14.87M+2.3% | $17.48M+9.4% | $14.36M-13.4% | $16M-9.1% | |
| ES | $8.45M+25.7% | $8.05M+25.0% | $7.22M+6.1% | $6.34M+0.6% | $6.72M+14.5% | |
| IE | $41.66M+255% | $9.68M+76.6% | $22.1M+24.0% | $12.08M+4.9% | $11.74M+19.3% | |
| IL | $0-100% | $0-100% | $171K-82.5% | $140K-28.6% | $139K-68.5% | |
| MX | $7.04M+11.8% | $6.94M+11.4% | $6.26M+19.3% | $6.74M+19.7% | $6.3M+6.6% | |
| Other Countries | $1.19M+16.5% | $1.15M+16.3% | $1.17M+25.1% | $1.09M+44.7% | $1.02M+26.6% | |
| US | $88.81M-22.7% | $83.5M-28.1% | $94.05M-30.8% | $110.92M-16.4% | $114.88M-18.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Opko Health break its business down?
- Opko Health (OPK) reports segment reporting other item amount by business across 2 parts — Diagnostics and Pharmaceutical. Each is extracted from the segment footnotes and tracked over time.
- Where does Opko Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Opko Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
